Support from the Sunshine State for HR842

July 24, 2013

On Tuesday, Representative Bill Posey of Florida's 8th congressional district became a cosponsor of The Functional Gastrointestinal and Motility Disorders Research Enhancement Act (H.R. 842).

Representative Posey was also a cosponsor of The Functional Gastrointestinal and Motility Disorders Research Enhancement Act when it was under consideration by the 112th Congress. We appreciate his continued support of functional gastrointestinal and motility disorders (FGIMDs) in the 113th Congress.

Congressman Posey is the 12th Representative to add their name to H.R. 842, joining colleagues Sensenbrenner (WI-5), Moran (VA-8), Brownley (CA-26), Moore (WI-4), Rush (IL-1), Kind (WI-3), Davis (CA-53), Welch (VT), McGovern (MA-2), Connolly (VA-11), and Slaughter (NY-25) in support of this critical legislation.

Is Congressman Posey your Representative?

If you live in Florida's 8th congressional district, please send a quick email to Representative Posey thanking him for his continued support of The Functional GI and Motility Disorders Research Enhancement Act

Is your Representative not yet a cosponsor?

Do not assume that your Representative is aware of this bill! There are thousands of bills for Congress to consider every session, but only a small number of these will ever become law. You can help The FGIMD Research Enhancement Act be one of these few. 

As a constituent you have the power to make H.R. 842 stand out.  Please take a few minutes of your time to email your Representative about The FGIMD Research Enhancement Act: share how you are affected by a FGIMD, let them know that this bill is important, and ask them to support the millions like you who are affected by these chronic conditions.

About The FGIMD Research Enhancement Act

About one in four Americans is affected by a FGIMD.  Currently there are few treatment options for these disorders and no cures exist. These conditions can diminish a person’s quality of life and productivity levels, often disrupting employment and educational opportunities for individuals and leading to significant social and economic impacts on society.

The FGIMD Research Enhancement Act offers hope for these millions of Americans impacted by FGIMDs. In addition to raising critical awareness of these disorders and the needs of patients, passage of this legislation will:

  • Grant the National Institutes of Health (NIH) new authority to initiate innovative research projects
  • Establish a Centers of Excellence Program in this area
  • Coordinate research activities with the Department of Defense and the Veterans Administration when appropriate
  • Call on the Food and Drug Administration (FDA) to improve review, approval, and oversight of treatments for FGIMDs


To leave a comment you must login first, click here to login